Clinical Trial Update: A Multicenter, Open-label, Dose-finding Trial of OPC-41061 to Investigate Efficacy, Pharmacokinetics, Pharmacodynamics, and Safety in Patients With Carcinomatous Edema (Phase 2) [Phase 2]

View source ↗

Summary

Phase 2 open-label dose-finding trial evaluating OPC-41061 in carcinomatous edema has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinomatous Edema

Drugs mentioned

• OPC-41061

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Carcinomatous Edema | Phase 2 | Status: COMPLETED | Results posted: 2021-03-18